Provided by Tiger Trade Technology Pte. Ltd.

ARCELLX, INC.

115.05
-0.0500-0.04%
Post-market: 115.050.00000.00%18:24 EDT
Volume:479.54K
Turnover:55.17M
Market Cap:6.73B
PE:-28.27
High:115.13
Open:115.10
Low:115.02
Close:115.10
52wk High:115.13
52wk Low:47.86
Shares:58.48M
Float Shares:39.70M
Volume Ratio:0.84
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0700
EPS(LYR):-4.0700
ROE:-53.42%
ROA:-24.05%
PB:16.72
PE(LYR):-28.27

Loading ...

Gilead extends Arcellx tender offer to April 27 after regulatory clearances

Reuters
·
Yesterday

Gilead - Tender Offer Expiration Extended to April 27, 2026

THOMSON REUTERS
·
Yesterday

Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says

MT Newswires Live
·
Apr 08

Gilead Buying Another Cancer-Drug Partner -- Market Talk

Dow Jones
·
Apr 07

Gilead extends tender offer to acquire Arcellx

TIPRANKS
·
Apr 02

Gilead extends Arcellx tender offer deadline to April 24

Reuters
·
Apr 02

Gilead - Tender Offer Expiration Extended to 5:00 P.m. Et on April 24, 2026

THOMSON REUTERS
·
Apr 02

Gilead - Offer Price $115 per Share Plus $5 CVR Payable March 31, 2030, IF Sales Milestone Met

THOMSON REUTERS
·
Apr 02

Piper Sandler Remains a Hold on Arcellx Inc (ACLX)

TIPRANKS
·
Mar 31

Arcellx shareholders set to receive USD 115 per share in Gilead deal

Reuters
·
Mar 17

Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR

Reuters
·
Mar 06

Truist Financial Keeps Their Hold Rating on Arcellx Inc (ACLX)

TIPRANKS
·
Mar 02

Arcellx Inc : TD Cowen Cuts to Hold From Buy

THOMSON REUTERS
·
Mar 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Alkermes (ALKS) and Progyny (PGNY)

TIPRANKS
·
Mar 02

U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike

Reuters
·
Mar 02

Arcellx (ACLX) Posts US$228.9m TTM Loss Testing Bullish Profitability Narratives

Simply Wall St.
·
Feb 28

Arcellx FY 2025 collaboration revenue falls 79% to USD 22.3 million

Reuters
·
Feb 27

Arcellx Cut to Neutral From Buy by Guggenheim

Dow Jones
·
Feb 27

Guggenheim Downgrades Arcellx to Neutral From Buy, Adjusts PT to $115 From $120

MT Newswires Live
·
Feb 26

U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite

Reuters
·
Feb 26